Cargando…

A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs

Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through int...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yulan, Luo, Shangyi, Zhang, Xinxin, Zou, Chaoxia, Yuan, Huating, Liao, Gaoming, Xu, Liwen, Deng, Chunyu, Lan, Yujia, Zhao, Tingting, Gao, Xu, Xiao, Yun, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210054/
https://www.ncbi.nlm.nih.gov/pubmed/30216655
http://dx.doi.org/10.1002/1878-0261.12381
_version_ 1783367029919580160
author Deng, Yulan
Luo, Shangyi
Zhang, Xinxin
Zou, Chaoxia
Yuan, Huating
Liao, Gaoming
Xu, Liwen
Deng, Chunyu
Lan, Yujia
Zhao, Tingting
Gao, Xu
Xiao, Yun
Li, Xia
author_facet Deng, Yulan
Luo, Shangyi
Zhang, Xinxin
Zou, Chaoxia
Yuan, Huating
Liao, Gaoming
Xu, Liwen
Deng, Chunyu
Lan, Yujia
Zhao, Tingting
Gao, Xu
Xiao, Yun
Li, Xia
author_sort Deng, Yulan
collection PubMed
description Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through integrative analysis of 5918 tumors across 11 cancer types, we revealed that lncRNAs have undergone dramatic genomic alterations, many of which are mutually exclusive with well‐known cancer genes. Using the hypothesis of functional redundancy of mutual exclusivity, we developed a computational framework to identify driver lncRNAs associated with different cancer hallmarks. Applying it to pan‐cancer data, we identified 378 candidate driver lncRNAs whose genomic features highly resemble the known cancer driver genes (e.g. high conservation and early replication). We further validated the candidate driver lncRNAs involved in ‘Tissue Invasion and Metastasis’ in lung adenocarcinoma and breast cancer, and also highlighted their potential roles in improving clinical outcomes. In summary, we have generated a comprehensive landscape of cancer candidate driver lncRNAs that could act as a starting point for future functional explorations, as well as the identification of biomarkers and lncRNA‐based target therapy.
format Online
Article
Text
id pubmed-6210054
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62100542018-11-08 A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs Deng, Yulan Luo, Shangyi Zhang, Xinxin Zou, Chaoxia Yuan, Huating Liao, Gaoming Xu, Liwen Deng, Chunyu Lan, Yujia Zhao, Tingting Gao, Xu Xiao, Yun Li, Xia Mol Oncol Research Articles Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through integrative analysis of 5918 tumors across 11 cancer types, we revealed that lncRNAs have undergone dramatic genomic alterations, many of which are mutually exclusive with well‐known cancer genes. Using the hypothesis of functional redundancy of mutual exclusivity, we developed a computational framework to identify driver lncRNAs associated with different cancer hallmarks. Applying it to pan‐cancer data, we identified 378 candidate driver lncRNAs whose genomic features highly resemble the known cancer driver genes (e.g. high conservation and early replication). We further validated the candidate driver lncRNAs involved in ‘Tissue Invasion and Metastasis’ in lung adenocarcinoma and breast cancer, and also highlighted their potential roles in improving clinical outcomes. In summary, we have generated a comprehensive landscape of cancer candidate driver lncRNAs that could act as a starting point for future functional explorations, as well as the identification of biomarkers and lncRNA‐based target therapy. John Wiley and Sons Inc. 2018-10-02 2018-11 /pmc/articles/PMC6210054/ /pubmed/30216655 http://dx.doi.org/10.1002/1878-0261.12381 Text en © 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Deng, Yulan
Luo, Shangyi
Zhang, Xinxin
Zou, Chaoxia
Yuan, Huating
Liao, Gaoming
Xu, Liwen
Deng, Chunyu
Lan, Yujia
Zhao, Tingting
Gao, Xu
Xiao, Yun
Li, Xia
A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title_full A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title_fullStr A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title_full_unstemmed A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title_short A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
title_sort pan‐cancer atlas of cancer hallmark‐associated candidate driver lncrnas
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210054/
https://www.ncbi.nlm.nih.gov/pubmed/30216655
http://dx.doi.org/10.1002/1878-0261.12381
work_keys_str_mv AT dengyulan apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT luoshangyi apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zhangxinxin apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zouchaoxia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT yuanhuating apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT liaogaoming apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT xuliwen apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT dengchunyu apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT lanyujia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zhaotingting apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT gaoxu apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT xiaoyun apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT lixia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT dengyulan pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT luoshangyi pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zhangxinxin pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zouchaoxia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT yuanhuating pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT liaogaoming pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT xuliwen pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT dengchunyu pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT lanyujia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT zhaotingting pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT gaoxu pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT xiaoyun pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas
AT lixia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas